Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals …
WEBSep 10, 2024 · Alimera Has Filed Lawsuit in the Delaware Court of Chancery to Compel ANI to Close Merger Transaction and Honor its Contractual Obligations. Alimera Shareholders Approved Merger Agreement on ...
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
WEBPRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”).
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera …
WEB3 days ago · The Company expects closing of the acquisition of Alimera Sciences to be consummated and announced today, pending satisfaction or waiver of any remaining customary closing conditions.
ANI Pharmaceuticals completes acquisition of Alimera Sciences
WEB2 days ago · ANI Pharmaceuticals completes acquisition of Alimera Sciences. The acquisition strengthens the company’s rare disease segment, and adds 2 durable commercial assets, Iluvien and Yutiq with significant growth potential, expanding ANI’s foothold in strategic therapeutic area of ophthalmology.
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
WEB4 days ago · PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of...
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
WEBJun 25, 2024 · Alimera (ALIM) is set to be acquired by ANI Pharmaceuticals for approximately $381 million in upfront consideration. The transaction is expected to close in the third quarter of 2024.
ANI Pharmaceuticals and Alimera Sciences Announce Closing …
WEBSep 11, 2024 · Alimera Sciences falls after it sues ANI Pharmaceuticals to close deal (update) Seeking Alpha 3d Alimera Files Lawsuit Against ANI To Enforce Merger Deal, Stock Down Nearly 19%
Alimera Sciences shares jump by 77% after being acquired by ANI
WEBJun 24, 2024 · Alimera’s share price shot up by 77% in premarket trading today, following the announcement of the transaction, valued at $381m. The deal is expected to close in the third quarter (Q3) of 2024.
ANI Pharmaceuticals completes acquisition of Alimera Sciences
WEB2 days ago · ANI Pharmaceuticals finalized its acquisition of Alimera Sciences, according to a press release. The acquisition is part of ANI’s bid to grow its rare disease business as well as bolster...
Alimera Sciences Reports First Quarter 2024 Results
WEBMay 14, 2024 · Key First Quarter Financial Highlights: Net revenue of $23.0 million up 70% vs Q1 2023. Net loss of $6.3 million compared to a net loss of $5.0 million in Q1 2023. Positive adjusted EBITDA of $1.8...
- Some results have been removed